title: Severe acute hepatitis associated with morphazinamide therapy.
authors.forename: C
authors.initials: C
authors.lastname: Zavaglia
authors.forename: L
authors.initials: L
authors.lastname: Mondazzi
authors.forename: E
authors.initials: E
authors.lastname: Fesce
authors.forename: G
authors.initials: G
authors.lastname: Iamoni
authors.forename: F
authors.initials: F
authors.lastname: Lanzani
authors.forename: G
authors.initials: G
authors.lastname: Ideo
mesh_terms: D000208:Acute Disease; D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D007565:Jaundice / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis; D008111:Liver Function Tests; D011719:Pyrazines / Q000009:adverse effects*
chemical_list: D000995:Antitubercular Agents; D015415:Biomarkers; D011719:Pyrazines; C038993:morphazinamide